NCT02910726View on ClinicalTrials.gov

A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 13, 2016

Primary Completion Date

September 2, 2022

Study Completion Date

September 2, 2022

Conditions

Pediatric Patients With Solid Tumors

Interventions

PROCEDURE

Sentinel Lymph Node Biopsy

DRUG

indocyanine green (ICG)

Trial Locations (3)

10065

Memorial Sloan Kettering Cancer Center, New York

38105

St. Jude's Children's Research Hospital, Memphis

77030

Texas Children's Hospital, Houston

All Listed Sponsors

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02910726 - A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers | Biotech Hunter | Biotech Hunter